Lushang Freda Pharmaceutical Co (SHSE:600223) Accounts Payable & Accrued Expense : ¥856 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Lushang Freda Pharmaceutical Co Accounts Payable & Accrued Expense?

Lushang Freda Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥1,528 Mil) to Dec. 2023 (¥774 Mil) but then increased from Dec. 2023 (¥774 Mil) to Mar. 2024 (¥856 Mil).

Lushang Freda Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥23,151 Mil) to Dec. 2022 (¥26,526 Mil) but then declined from Dec. 2022 (¥26,526 Mil) to Dec. 2023 (¥774 Mil).

Lushang Freda Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lushang Freda Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lushang Freda Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Lushang Freda Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

24,184.96

24,289.60

23,150.69

26,525.79

773.60

Lushang Freda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,950.31	1,732.34	1,528.19	773.60	855.81

Lushang Freda Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lushang Freda Pharmaceutical Co (SHSE:600223) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN

Website

http://www.lshzy.com.cn

Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.

Executives

Li Hang	senior management
Yin Wei	Directors, senior managers
Shao Zhao Wei	senior management
Wang Zhong Wu	senior management
Dong Hong Lin	Director
Zhou Hong Bo	senior management
Li Lu	senior management
Liu Zeng Wei	senior management
Zhang Quan Li	senior management
Xu Tao	senior management
Ju Hai Bo	Director
Zhao Xi Liang	Director
Pi Xi Cai	Supervisors

Lushang Freda Pharmaceutical Co (SHSE:600223) Headlines

No Headlines